查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1990476

排泄管理系統市場：依產品類型、技術、年齡層及最終用戶分類－2026-2032年全球市場預測

Bowel Management Systems Market by Product Type, Technology, Age Group, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，排泄管理系統市值將達到 27.1 億美元，到 2026 年將成長至 28.5 億美元，到 2032 年將達到 39.5 億美元，複合年成長率為 5.50%。

主要市場統計數據
基準年 2025 27.1億美元
預計年份：2026年 28.5億美元
預測年份 2032 39.5億美元
複合年成長率 (%) 5.50%

本策略性介紹闡述了腸道管理系統的臨床、營運和市場背景，同時概述了病患需求和相關人員的價值創造因素。

在醫療設備創新、護理路徑重新設計以及人口和臨床因素導致的需求成長的推動下，腸道管理系統正日益成為臨床關注的焦點。神經源性腸道功能障礙、術後腸道功能障礙和慢性尿失禁患者需要兼顧臨床療效、易用性和尊嚴的解決方案。臨床醫生和醫療保健系統越來越關注提高患者的生活品質、促進不同護理機構之間的過渡以及最大限度地減少皮膚損傷和感染疾病等併發症。因此，產品開發人員和供應商必須提供既符合臨床績效指標又符合實際易用性的設備和方案。

近期臨床創新、醫療服務分散化和供應鏈重組如何從根本上改變腸道管理系統的模式？

腸道管理系統正經歷一系列變革，重塑產品設計、照護模式和商業策略。微型化、生物材料和低電壓神經調控技術的進步為主動式系統開闢了新的可能性，使得更舒適、更微創的設備成為可能，適用於長期門診使用。同時，被動式解決方案也在不斷發展，透過符合人體工學的設計、氣味控制和更佳的佩戴舒適度來滿足居家照護的需求。這些改進體現了對患者體驗和治療依從性的日益重視，進而加速了醫療專業人員的接受度和支付方的關注。

本研究評估了近期關稅壓力和貿易政策調整如何促使糞便管理系統的供應鏈、製造本地化和籌資策略進行調整。

關稅政策和貿易趨勢的變化會對廢棄物管理系統生態系統造成重大壓力，尤其是在關鍵零件和成品跨境運輸的情況下。進口關稅的提高可能會增加原料、特殊聚合物、電子元件和成品醫療設備的到貨成本，迫使製造商重新評估其籌資策略和生產地點。作為應對措施，醫療器材製造商可能會加快生產本地化進程，認證新的供應商，或重新設計產品以使用受關稅影響較小的替代材料。雖然這些策略措施有助於維持利潤率，但它們需要資本投入、核准監管部門的批准以及嚴格的品管。

關鍵細分洞察表明，醫療保健機構的分類和醫療設備的技術分類如何對設計、證據和商業化產生不同的要求。

排泄管理領域的細分凸顯了基於醫療機構和技術分類制定差異化產品策略的必要性。按最終用戶分類，該市場涵蓋門診診所、居家照護、醫院和長期護理機構。門診護理進一步細分為診所和門診手術中心；居家照護分為看護者輔助護理和自我管理護理；醫院分為綜合醫院和專科醫院；長期護理機構包括輔助生活住宅和療養院。每種環境都有其獨特的限制和機會。門診診所優先考慮快速的患者周轉和門診手術流程；居家照護需要簡單易用並為看護者提供支持；醫院需要與急診護理通訊協定兼容；而長期護理則強調產品的耐用性和日常管理的便捷性。

區域採用模式和監管現實塑造了世界各地市場准入、臨床參與和商業化策略的差異。

區域趨勢對腸道管理系統的部署模式、監管路徑和商業策略有顯著影響。在美洲，保險公司和綜合醫療保健系統優先考慮基於療效的採購，通常需要強力的臨床證據來支持報銷決策，這反過來又會影響產品開發藍圖和臨床試驗的優先順序。北美法規環境強調明確的醫療設備分類和明確的臨床終點，其分銷網路涵蓋醫院直接採購和專業的居家照護管道，因此需要靈活的銷售和支援模式。

富有洞察力的企業級趨勢揭示了夥伴關係、循證策略和設計驅動的差異化如何決定競爭定位和成長軌跡。

排泄管理系統領域的競爭格局呈現出多元化的特點，既有成熟的醫療設備製造商，也有專注於創新領域的專業企業、契約製造以及數位醫療領域的新興參與企業。主要企業正著力打造整合解決方案，將可靠的硬體與病患教育、看護者培訓和遠端監測等服務要素結合。其策略重點包括：透過研究者主導的研究和贊助的臨床試驗累積臨床證據；與居家照護機構和醫院集團採購組織建立長期經銷夥伴；以及透過以使用者為中心的設計實現差異化，從而降低臨床醫生和看護者的學習難度。

為醫療設備製造商、供應商和投資者提供切實可行的策略建議，以加速產品應用、降低風險並建立永續的競爭優勢。

產業領導者應採取一系列切實可行的措施，加速產品推廣應用、降低風險並建立永續的競爭優勢。首先，他們應優先產生符合支付方優先事項和臨床終點的證據，投資於真實世界研究和衛生經濟學評估，以證明產品能夠減少併發症、減輕看護者負擔並降低整體醫療資源利用率。同時，他們應在產品設計中融入模組化理念，使單一平台能夠滿足從急診醫院到家庭自我管理等多種護理環境的需求。這將在不增加產品種類的情況下，拓展產品的使用範圍。

我們嚴謹的混合方法研究途徑，結合了對臨床醫生的訪談、監管審查和證據的三角檢驗，產生了引人注目且可操作的見解。

本研究途徑基於混合方法框架，結合一手定性資料、結構化二手研究以及透過多種調查方法進行的三角驗證，從而確保獲得穩健且引人入勝的洞見。一手研究包括對急診、門診、長期照護和居家照護機構的臨床醫生進行詳細訪談，與採購經理進行諮詢，以及與醫療設備工程師和監管專家進行對話。透過這些對話，我們得以揭示已發表文獻中未必會提及的真實工作流程、未滿足的需求以及推廣應用障礙。二手資訊包括同行評審的臨床研究、監管指導文件、產品標籤和公開的臨床註冊資訊，這些資訊共同構成了技術和臨床背景的基礎。

簡潔的結論強調，實證創新、穩健的營運系統和以病人為中心的模式是排泄管理系統未來成功的支柱。

總之，排泄管理系統處於臨床需求、技術可能性和不斷發展的醫療服務模式的交匯點。以患者為中心的設計、可靠的臨床證據和靈活的商業化策略將決定哪些解決方案能夠被廣泛採用。分散式醫療的興起和居家照護的增加凸顯了易用性、看護者支援和遠端監測的重要性。同時，主動式技術為功能恢復提供了機會，但也需要對臨床醫生進行培訓並與結果數據保持一致。相關人員，將最有利於實現臨床影響和商業性成功。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：排泄管理系統市場：依產品類型分類

  • 清潔系統
  • 神經刺激設備
  • 結腸支架
  • 配件

第9章：排泄管理系統市場：依技術分類

  • 手動系統
  • 自動化/電氣系統

第10章：排泄管理系統市場：依年齡層別分類

  • 兒童
  • 成人版
  • 老年人

第11章：排泄管理系統市場：依最終用戶分類

  • 門診部
  • 居家照護環境
    • 看護者援助
    • 自我管理
  • 醫院
  • 長期照護
    • 輔助住宅
    • 護理機構

第12章：排泄管理系統市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：排泄管理系統市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：排泄管理系統市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國廢棄物管理系統市場

第16章：中國廢棄物管理系統市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Axonics, Inc.
  • B. Braun Medical Ltd
  • Becton, Dickinson, and Company
  • Coloplast Pty Ltd
  • Consure Medical
  • Convatec Inc.
  • Dentsply Sirona Group
  • Eakin Healthcare Group
  • Hollister Incorporated
  • HR HealthCare, Inc.
  • Laborie Group
  • Medtronic Limited
  • Pentland Medical Ltd.
  • Prosys International Ltd.
  • Qufora A/S
  • Renew Medical Inc.
  • Sayco Pty Ltd
  • Welland Medical Limited.
Product Code: MRR-3A68B8397AE7

The Bowel Management Systems Market was valued at USD 2.71 billion in 2025 and is projected to grow to USD 2.85 billion in 2026, with a CAGR of 5.50%, reaching USD 3.95 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.71 billion
Estimated Year [2026] USD 2.85 billion
Forecast Year [2032] USD 3.95 billion
CAGR (%) 5.50%

A strategic introduction that sets the clinical, operational, and market context for bowel management systems while framing patient needs and stakeholder value drivers

Bowel management systems have become a focal point of clinical practice, combining device innovation, care pathway redesign, and growing demand driven by demographic and clinical factors. Patients with neurogenic bowel dysfunction, postoperative bowel disturbances, and chronic incontinence now require solutions that balance clinical efficacy, ease of use, and dignity. Clinicians and health systems are increasingly focused on minimizing complications such as skin breakdown and infection while improving quality of life and enabling transitions across care settings. Consequently, product developers and providers are pressured to deliver devices and programs that meet both clinical performance metrics and real-world usability standards.

Across the care continuum, stakeholders are aligning around integrated models that emphasize patient-centered care. Acute care teams aim to reduce length of stay and readmissions by improving bowel management protocols, while long-term and home care providers emphasize sustained adherence and reduced caregiver burden. These converging priorities have catalyzed investment in both passive solutions that simplify care routines and active technologies that restore or augment function. Simultaneously, payers and procurement teams scrutinize total cost of care implications, driving demand for evidence that links device use to measurable improvements in clinical outcomes and resource utilization. In this environment, clarity about clinical pathways, regulatory requirements, and stakeholder expectations becomes essential for innovators and investors alike.

How recent clinical innovations, care delivery decentralization, and supply chain reconfiguration are fundamentally reshaping the bowel management systems landscape

The landscape for bowel management systems is undergoing a series of transformative shifts that are reshaping product design, care delivery, and commercial strategy. Technological advances in miniaturization, biomaterials, and low-voltage neuromodulation have opened new possibilities for active systems, enabling devices that are more comfortable, less invasive, and better suited for prolonged outpatient use. At the same time, passive solutions have evolved toward improved ergonomics, odor control, and wearability to meet home care demands. These enhancements reflect a broader focus on patient experience and adherence, which in turn accelerates clinician acceptance and payer interest.

Concurrently, the delivery model for bowel care is decentralizing. Greater emphasis on at-home care, caregiver-assisted regimens, and remote monitoring aligns with broader healthcare trends toward value-based care and reduced institutional utilization. Integration with electronic medical records and telehealth platforms allows clinicians to monitor adherence, titrate therapies, and intervene earlier when complications emerge. Supply chain and manufacturing strategies are also shifting, with stakeholders prioritizing resilient sourcing, nearshoring options, and partnership models that can adapt to regulatory and trade policy changes. Collectively, these shifts create both opportunities and challenges: manufacturers must balance rapid innovation with robust clinical evidence, while providers must redesign care pathways and training to realize the full potential of next-generation bowel management solutions.

Assessing how recent tariff pressures and trade policy adjustments are recalibrating supply chains, manufacturing localization, and procurement strategies in bowel management systems

Changes to tariff policy and trade dynamics can exert meaningful pressure on the bowel management systems ecosystem, particularly where key components or finished devices cross borders. Higher import levies can increase the landed cost of raw materials, specialized polymers, electronic components, and finished medical devices, prompting manufacturers to reassess sourcing strategies and production footprints. In response, device makers may accelerate localization of manufacturing, qualify new suppliers, or redesign products to use alternate materials that are less exposed to tariff vulnerabilities. These strategic moves help protect margins but require capital investment, regulatory reapprovals, and careful quality management.

Procurement teams and health systems also adapt to tariff-driven cost shifts by revising contracting strategies, aggregating demand across networks, and seeking multi-year supplier commitments to stabilize pricing. Private and public payers may scrutinize device pricing more closely, pressing manufacturers for evidence that increased costs translate into clinical or economic value. At the same time, distributors and integrated providers can leverage inventory management techniques and longer lead times to smooth short-term price volatility. Importantly, tariff-induced headwinds can spur strategic consolidation, as companies pursue vertical integration to control costs, or conversely, encourage new entrants who target lower-cost manufacturing models. The cumulative impact is a recalibration of how manufacturers prioritize capital allocation, where suppliers locate production, and how providers evaluate the trade-offs between device cost, clinical benefit, and operational simplicity.

Critical segmentation insights demonstrating how care setting distinctions and device technology classes create divergent requirements for design, evidence, and commercialization

Segmentation of the bowel management space underscores the need for differentiated product strategies across care settings and technology classes. Based on end user, the landscape spans ambulatory care centers, home care settings, hospitals, and long-term care, with ambulatory care further defined by clinics and outpatient surgical centers, home care distinguished between caregiver-assisted and self-administered modalities, hospitals categorized into general and specialty facilities, and long-term care encompassing assisted living facilities and nursing homes. Each setting imposes distinct constraints and opportunities: ambulatory clinics prioritize rapid turnover and outpatient procedural workflows, home care demands simplicity and caregiver support, hospitals require compatibility with acute care protocols, and long-term care emphasizes durability and ease of daily management.

Technology segmentation also matters. Based on passive bowel management systems, the market includes external collection devices, with subcategories such as absorbent products and drainage bags that must balance capacity, comfort, and infection control considerations. Based on active bowel management systems, technologies include balloon catheters and electrostimulation systems that necessitate higher clinical training, procedural pathways, and evidence generation to drive clinician and payer acceptance. The interplay between end-user segmentation and technological approach shapes product design priorities: devices intended for self-administration must simplify interface and maintenance, while those for hospital or specialty settings can leverage advanced features but must justify complexity with demonstrable clinical benefits. Understanding these nuanced segmentation dynamics enables more precise go-to-market approaches, pricing frameworks, and clinical engagement plans.

Regional adoption patterns and regulatory realities that shape differentiated market access, clinical engagement, and commercialization strategies across global territories

Regional dynamics exert a significant influence on adoption patterns, regulatory pathways, and commercial strategies for bowel management systems. In the Americas, payers and integrated health systems emphasize outcome-based purchasing and often require robust clinical evidence to support reimbursement decisions, which in turn shapes product development roadmaps and clinical trial priorities. The regulatory environment in North America favors clear device classification and well-defined clinical endpoints, while distribution networks span both direct hospital procurement and specialized home care channels, necessitating flexible sales and support models.

In Europe, the Middle East & Africa region, diversity in regulatory frameworks and reimbursement mechanisms creates a patchwork of adoption conditions, with some markets driven by national procurement programs and others by private payers. Local clinical guidelines and long-term care infrastructure vary significantly across countries, so regional strategies must combine centralized evidence generation with tailored market access tactics. In the Asia-Pacific region, rapid demographic aging in certain countries and expanding home healthcare ecosystems are increasing demand for both passive and active solutions, but manufacturers must navigate a range of regulatory standards, local manufacturing incentives, and price sensitivity. Across regions, successful commercialization demands an appreciation for local clinical practices, procurement norms, and the interplay between public policy and private sector purchasing behavior.

Insightful company-level dynamics revealing how partnerships, evidence strategies, and design differentiation determine competitive positioning and growth pathways

Competitive dynamics in bowel management systems are defined by a mix of established medical device manufacturers, focused specialty innovators, contract manufacturers, and digital health entrants. Leading organizations emphasize integrated solutions that combine reliable hardware with service elements such as patient education, caregiver training, and remote monitoring. Strategic priorities often include building clinical evidence through investigator-initiated studies and sponsored trials, establishing durable distribution partnerships with home care providers and hospital group purchasing organizations, and differentiating through user-centered design that reduces the learning curve for clinicians and caregivers.

Smaller, agile companies frequently pursue niche clinical indications or rapid iterations in materials and usability to secure early adoption, while larger players leverage scale to support reimbursement discussions and global regulatory filings. Across company types, partnerships between device manufacturers and digital-health providers are increasingly common, aimed at improving adherence monitoring and remote clinical support. Investors and corporate development teams are watching for consolidation opportunities that can simplify supply chains or broaden clinical portfolios, while R&D organizations prioritize incremental innovations that lower procedural complexity, improve patient comfort, and reduce adverse events. These strategic moves influence competitive positioning and determine which solutions gain traction among clinicians, caregivers, and payers.

Actionable strategic recommendations for device makers, providers, and investors to accelerate adoption, mitigate risk, and build durable competitive advantage

Industry leaders should adopt a set of pragmatic actions to accelerate adoption, reduce risk, and create sustainable competitive advantage. First, prioritize evidence generation that aligns with payer priorities and clinical endpoints; invest in real-world studies and health economic evaluations that demonstrate reductions in complications, caregiver burden, and overall care utilization. Simultaneously, design products with modularity in mind so a single platform can address multiple care settings-from acute hospitals to home-based self-administration-thereby increasing addressable use cases without multiplying SKUs.

Second, diversify supply chains and evaluate localized manufacturing or contract manufacturing partnerships to mitigate tariff and trade disruptions, while maintaining rigorous quality oversight. Third, build comprehensive go-to-market models that bundle devices with digital support, clinician training, and caregiver resources to facilitate faster uptake; these value-added services can create stickiness with customers and justify premium positioning. Finally, engage proactively with regulators and payers to align clinical endpoints and reimbursement pathways early in development, and collaborate with clinical champions to drive guideline inclusion and professional society endorsement. Implementing these actions in a coordinated manner helps translate technological advances into measurable clinical and commercial outcomes.

A rigorous mixed-methods research approach blending clinician interviews, regulatory review, and evidence triangulation to produce defensible and actionable insights

The research approach relies on a mixed-methods framework combining primary qualitative inputs, structured secondary research, and methodological triangulation to ensure robust, defensible insights. Primary research includes in-depth interviews with clinicians across acute, ambulatory, long-term, and home care settings, discussions with procurement leaders, and dialogues with device engineers and regulatory specialists. These conversations illuminate real-world workflows, unmet needs, and adoption barriers that are not always visible in published literature. Secondary sources include peer-reviewed clinical studies, regulatory guidance documents, product labeling, and publicly available clinical registries, which together provide a foundation for technical and clinical context.

Data validation occurs through cross-referencing interview findings with published clinical evidence and regulatory records, and through advisory panels comprising practicing clinicians who provide critique and contextual feedback on draft findings. The methodology explicitly documents limitations, such as variability in regional regulatory interpretation and the evolving nature of reimbursement policy, and it employs conservative language where evidence is emerging. This transparent and iterative research design supports practical recommendations and allows stakeholders to understand the evidentiary basis for conclusions and to request bespoke analyses tailored to specific geographies or clinical subsegments.

A concise conclusion emphasizing evidence-driven innovation, resilient operations, and patient-centric models as pillars for future success in bowel management systems

In conclusion, bowel management systems sit at the intersection of clinical need, technological possibility, and changing care delivery models. Patient-centered design, robust clinical evidence, and adaptive commercialization strategies will determine which solutions gain broad adoption. The shift toward decentralized care and increased home management elevates the importance of usability, caregiver support, and remote monitoring, while active technologies present opportunities for functional restoration that must be matched with clinician training and outcome data. Industry participants who align product development with payer expectations and regulatory clarity will be best positioned to realize both clinical impact and commercial success.

As the ecosystem continues to evolve, stakeholders must remain responsive to policy shifts, supply chain dynamics, and regional heterogeneity in care delivery. Collaborative approaches that unite manufacturers, providers, and payers around measurable goals-reduced complications, improved quality of life, and efficient care transitions-will accelerate progress. By focusing on evidence-driven innovation, resilient operations, and patient-centric service models, the sector can deliver meaningful improvements for patients while creating sustainable business value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bowel Management Systems Market, by Product Type

  • 8.1. Irrigation Systems
  • 8.2. Neurostimulation Devices
  • 8.3. Colonic Stents
  • 8.4. Accessories

9. Bowel Management Systems Market, by Technology

  • 9.1. Manual Systems
  • 9.2. Automated/Electric Systems

10. Bowel Management Systems Market, by Age Group

  • 10.1. Pediatric
  • 10.2. Adult
  • 10.3. Geriatric

11. Bowel Management Systems Market, by End User

  • 11.1. Ambulatory Care Centers
  • 11.2. Home Care Settings
    • 11.2.1. Caregiver Assisted
    • 11.2.2. Self Administered
  • 11.3. Hospitals
  • 11.4. Long Term Care
    • 11.4.1. Assisted Living Facilities
    • 11.4.2. Nursing Homes

12. Bowel Management Systems Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Bowel Management Systems Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Bowel Management Systems Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Bowel Management Systems Market

16. China Bowel Management Systems Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Axonics, Inc.
  • 17.6. B. Braun Medical Ltd
  • 17.7. Becton, Dickinson, and Company
  • 17.8. Coloplast Pty Ltd
  • 17.9. Consure Medical
  • 17.10. Convatec Inc.
  • 17.11. Dentsply Sirona Group
  • 17.12. Eakin Healthcare Group
  • 17.13. Hollister Incorporated
  • 17.14. HR HealthCare, Inc.
  • 17.15. Laborie Group
  • 17.16. Medtronic Limited
  • 17.17. Pentland Medical Ltd.
  • 17.18. Prosys International Ltd.
  • 17.19. Qufora A/S
  • 17.20. Renew Medical Inc.
  • 17.21. Sayco Pty Ltd
  • 17.22. Welland Medical Limited.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BOWEL MANAGEMENT SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY IRRIGATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY IRRIGATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY IRRIGATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY NEUROSTIMULATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY NEUROSTIMULATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY NEUROSTIMULATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY COLONIC STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY COLONIC STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY COLONIC STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY MANUAL SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY MANUAL SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY MANUAL SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AUTOMATED/ELECTRIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AUTOMATED/ELECTRIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AUTOMATED/ELECTRIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY CAREGIVER ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY CAREGIVER ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY CAREGIVER ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY SELF ADMINISTERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY SELF ADMINISTERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY SELF ADMINISTERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY LONG TERM CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY LONG TERM CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY LONG TERM CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY LONG TERM CARE, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY ASSISTED LIVING FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY ASSISTED LIVING FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY ASSISTED LIVING FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY NURSING HOMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY NURSING HOMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY LONG TERM CARE, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY LONG TERM CARE, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY LONG TERM CARE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY LONG TERM CARE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY LONG TERM CARE, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY LONG TERM CARE, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY LONG TERM CARE, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY LONG TERM CARE, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY LONG TERM CARE, 2018-2032 (USD MILLION)
  • TABLE 124. GCC BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GCC BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. GCC BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. GCC BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GCC BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. GCC BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 130. GCC BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY LONG TERM CARE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY LONG TERM CARE, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY LONG TERM CARE, 2018-2032 (USD MILLION)
  • TABLE 145. G7 BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. G7 BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. G7 BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. G7 BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. G7 BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. G7 BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 151. G7 BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY LONG TERM CARE, 2018-2032 (USD MILLION)
  • TABLE 152. NATO BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. NATO BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NATO BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. NATO BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. NATO BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. NATO BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 158. NATO BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY LONG TERM CARE, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES BOWEL MANAGEMENT SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY LONG TERM CARE, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. CHINA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA BOWEL MANAGEMENT SYSTEMS MARKET SIZE, BY LONG TERM CARE, 2018-2032 (USD MILLION)